The synergistic health syndemic of HIV and cancer of the cervix in women living with HIV in sub-Saharan Africa: Decrying the dearth of information
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i12.2708Keywords:
women, cervical cancer, Antiretroviral Therapy, HIVAbstract
-
References
1. United Nations Interagency Task Force on non-communicable diseases. Responding to the challenges of non-communicable diseases. New York: UNDP, 2019. https://www.undp.org/publications/ responding-challenge-non-communicable-diseases (accessed 22 January 2024).
2. Moyo-Chilufya M, Maluleke K, Kgarosi K, Muyoyeta M, Hongoro C, Musekiwa A. The burden of non- communicable diseases among people living with HIV in sub-Saharan Africa: A systematic review and meta-analysis. E Clinical Med 2023;65:102255. https://doi.org/10.1016/j.eclinm.2023.102255
3. Patel P, Rose CE, Collins PY, et al. Non-communicable diseases among HIV-infected persons in low- income and middle-income countries: A systematic review and meta-analysis. Aids 2018;32(Suppl 1):S5-S20. https://doi.org/10.1097/qad.0000000000001888
4. Joint United Nations Programme on HIV/AIDS. UNAIDS Data 2021. New York: UNASIDS, 2021.
https://www.unaids.org/sites/default/files/media_asset/JC3032_AIDS_Data_book_2021_En.pdf
(accessed 11 October 2024).
5. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018:
GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA:
Cancer J Clinicians 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
6. Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer
in 2020: A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob
Health 2023;11(2):e197-e206. https://doi.org/10.1016/S2214-109X(22)00501-0
7. Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with
HIV. Lancet Glob Health 2021;9(2):e161-e169. https://doi.org/10.1016/S2214-109X(20)30459-9
8. Khalil IA, Mpunga T, Wei F, et al. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. Int J Cancer 2022;150(5):761-772. https://doi.
org/10.1002/ijc.33841
9. Poljak M, Šterbenc A, Lunar MM. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV). Expert Rev Anti-Infect Ther 2017;15(11):987-999. https://doi.org/10.1080/14787210.2017.1392854.
10. Palefsky JM. Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: Incidence and prevention in the antiretroviral therapy era. Curr Opin HIV AIDS 2017;12(1):26-30. https://doi.org/10.1097/COH.0000000000000336.
11. World Health Organization. IARC monographs on the identification of carcinogenic hazards to humans. Geneva: WHO, 2024. https://monographs.iarc.who.int/agents-classified-by-the-iarc/2024 (accessed 7 September 2024).
12. Mowla S, Ahmed R. HIV infection and the risk of cancer: Tumorigenicity of HIV-1 auxiliary proteins. Fut Virol 2022;17(10):707-710.
13. Isaguliants M, Bayurova E, Avdoshina D, Kondrashova A, Chiodi F, Palefsky JM. Oncogenic effects of HIV-1 proteins, mechanisms behind. Cancers 2021;13(2):305. https://doi.org/10.3390/cancers13020305 14. Stier EA, Baranoski AS. Human papillomavirus-related diseases in HIV-infected individuals. Curr
Opin Oncol 2008;20(5):541-546. https://doi.org/10.1097/CCO.0b013e3283094ed8.
15. Minkoff H, Zhong Y, Burk RD, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency
virus-positive women. J Infect Dis 2010;201(5):681-690. https://doi.org/10.1086/650467
16. Grulich AE, Van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007;370(9581):59-
67. https://doi.org/10.1016/S0140-6736(07)61050-2.
17. Kelly H, Weiss HA, Benavente Y, et al. Association of antiretroviral therapy with high-risk human
papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: A systematic review and meta-analysis. Lancet HIV 2018;5(1):e45-e58. https://doi.org/10.1016/ S2352-3018(17)30149-2
18. Rohner E, Bütikofer L, Schmidlin K, et al. Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int J Cancer 2020;146(3):601-609. https://doi.org/10.1002/ijc.32260
19. Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. Aids 2018;32(6):795-808. https://doi. org/10.1097/QAD.0000000000001765
20. ICO/IARC Information Centre on HPV and Cancer. Human papillomavirus and related diseases report: South Africa. Barcelona: HPV Information Centre, 2019.
21. Markowitz LE, Schiller JT. Human papillomavirus vaccines. J Infect Dis 2021; 224 (Supplement_4):S367-S378. https://doi.org/10.1093/infdis/jiaa621.
22. Engels EA, Shiels MS, Barnabas RV, et al. State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI. Int J Cancer 2024;154(4):596- 606. https://doi.org/10.1002/ijc.34727
23. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J National Cancer Inst 2005;97(6):425-432. https://doi.org/10.1093/jnci/dji072
24. Lekoane KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: Scoping review. System Rev 2020;9(1):1-13. https://doi.org/10.1186/s13643-020-01354-1
25. Denslow SA, Rositch AF, Firnhaber C, Ting J, Smith JS. Incidence and progression of cervical lesions in women with HIV: A systematic global review. Int J STD AIDS 2014;25(3):163-177. https://doi. org/10.1177/0956462413491735
Downloads
Published
Issue
Section
License
Copyright (c) 2024 S Sibeko, M Sebitloane, S Moyo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
